Which are the causes of Crigler-Najjar syndrome?

TL;DR: Crigler-Najjar syndrome is a rare, inherited metabolic disorder caused by mutations in the UGT1A1 gene, which prevent the liver from properly processing bilirubin. This genetic defect leads to a dangerous buildup of unconjugated bilirubin in the blood, potentially resulting in severe neurological complications if left untreated.

What exactly causes Crigler-Najjar syndrome?

At its core, Crigler-Najjar syndrome is a metabolic "bottleneck." In a healthy liver, an enzyme called bilirubin-UGT (uridine diphosphate-glucuronosyltransferase) acts like a chemical gatekeeper; it attaches a sugar molecule to bilirubin—a yellow waste product from the normal breakdown of red blood cells—so it can be dissolved in bile and safely excreted from the body. In patients with Crigler-Najjar syndrome, this enzyme is either severely deficient or completely absent. Because the "gatekeeper" is missing, bilirubin cannot be processed, causing it to accumulate to toxic levels in the bloodstream and tissues.

Is Crigler-Najjar syndrome hereditary?

Yes, Crigler-Najjar syndrome is an autosomal recessive genetic condition. This means that for a child to be born with the disorder, they must inherit two copies of the mutated UGT1A1 gene—one from each parent. Parents who are carriers of a single mutated gene typically do not show symptoms themselves, as they have enough functional enzyme activity to maintain normal bilirubin levels. Because it is strictly genetic, there are no environmental triggers, infections, or lifestyle factors that cause the development of Crigler-Najjar syndrome.

What are the genetic mechanisms behind the syndrome?

The UGT1A1 gene is located on chromosome 2 (specifically at 2q37.1). Research has identified over 100 different mutations within this gene that can lead to the disease. These mutations are categorized into two distinct types based on the severity of the enzyme deficiency:

• Type I (Complete deficiency): There is no functional bilirubin-UGT enzyme activity. This is the more severe form, often requiring lifelong phototherapy or liver transplantation.


• Type II (Partial deficiency): Patients retain a small amount of residual enzyme activity, often less than 10% of normal levels. These individuals generally have lower bilirubin levels and may respond to medications like phenobarbital.

Is the cause fully understood or is research ongoing?

While we fully understand the underlying genetic cause—the UGT1A1 mutation—researchers are still actively studying how to optimize treatments and explore curative approaches. Current research into the etiology of Crigler-Najjar syndrome is focused on gene therapy, which aims to introduce a healthy, functional copy of the UGT1A1 gene into the liver cells. By "fixing" the genetic code at the source, scientists hope to provide a long-term alternative to daily phototherapy or the risks associated with liver transplantation. The 35 members of the Crigler-Najjar syndrome community on DiseaseMaps.org reflect the diversity of experiences with this condition, highlighting the ongoing need for personalized management strategies.

Next steps

• Consult a metabolic specialist or a hepatologist (liver specialist) to confirm your specific genetic mutation and treatment plan.


• Request a referral to a clinical geneticist for family counseling to understand the inheritance risks for future generations.


• Connect with the Crigler-Najjar syndrome community at DiseaseMaps.org to share experiences and stay updated on clinical trial opportunities.


• Ensure you are monitored regularly for bilirubin levels to prevent the risk of kernicterus (bilirubin-induced brain damage).

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Crigler-Najjar syndrome.


• Orphanet: Rare Disease Database - Crigler-Najjar syndrome (ORPHA207).


• OMIM (Online Mendelian Inheritance in Man): UGT1A1 Gene and Crigler-Najjar syndrome.


• PubMed: Clinical and molecular aspects of bilirubin metabolism disorders.